COGT logo

Cogent Biosciences, Inc. (COGT) Accounts Receivable

Annual Accounts Receivable:

N/A
December 31, 2024

Summary

  • COGT annual accounts receivable is not available.

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

COGT Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

$2.00M
COGT annual accounts receivable is currently at an all-time high

3-Year Low

-
COGT annual accounts receivable 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
COGT previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
COGT next annual earnings announcement has not yet been scheduled

OtherCOGTbalance sheet metrics

Annual Accounts Payable

$12.01M
COGT annual accounts payable is $12.01 million

Annual Total Assets

$327.90M
COGT annual total assets is $327.90 million

Annual Total Liabilities

$71.61M
COGT annual total liabilities is $71.61 million

Annual Cash & Cash Equivalents

$287.08M
COGT annual cash & cash equivalents is $287.08 million

Quarterly Accounts Receivable:

N/A
June 30, 2025

Summary

  • COGT quarterly accounts receivable is not available.

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

COGT Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

$2.04M
COGT quarterly accounts receivable is currently at an all-time high

3-Year Low

-
COGT quarterly accounts receivable 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
COGT previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

N/A
COGT next earnings announcement has not yet been scheduled

OtherCOGTbalance sheet metrics

Quarterly Accounts Payable

$16.63M
COGT quarterly accounts payable is $16.63 million

Quarterly Total Assets

$274.82M
COGT quarterly total assets is $274.82 million

Quarterly Total Liabilities

$119.78M
COGT quarterly total liabilities is $119.78 million

Quarterly Cash & Cash Equivalents

$237.85M
COGT quarterly cash & cash equivalents is $237.85 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

COGT Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year--
3Y3 Years--
5Y5 Years--

COGT Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year
5Y5-Year
All-TimeAll-Time

COGT Accounts Receivable History

DateAnnualQuarterly
Dec 2020
$0.00(-100.0%)
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
Mar 2020
-
$0.00(-100.0%)
Dec 2019
$2.00M(+19.9%)
$2.00M(+127.3%)
Sep 2019
-
$880.00K(-41.0%)
Jun 2019
-
$1.49M(-26.9%)
Mar 2019
-
$2.04M(+22.3%)
DateAnnualQuarterly
Dec 2018
$1.67M(+101.0%)
$1.67M(+17.5%)
Sep 2018
-
$1.42M(+18.1%)
Jun 2018
-
$1.20M(-24.9%)
Mar 2018
-
$1.60M(+92.9%)
Dec 2017
$830.00K(-10.6%)
$830.00K(-45.1%)
Sep 2017
-
$1.51M
Dec 2016
$928.00K(+215.6%)
-
Dec 2015
$294.00K
-

FAQ

  • What is the all-time high annual accounts receivable for Cogent Biosciences, Inc.?
  • What is the all-time high quarterly accounts receivable for Cogent Biosciences, Inc.?

What is the all-time high annual accounts receivable for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual accounts receivable is $2.00M

What is the all-time high quarterly accounts receivable for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly accounts receivable is $2.04M
On this page